HILLARY BURKS: Open Payments
NPI 1891205357 · COLUMBIA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$633 in 27 payments from 11 companies in 2025. Trend: 2023 $539 · 2024 $450 · 2025 $633
Food & beverage: $633
| Company | Payments | Amount |
|---|---|---|
| Biosense Webster, Inc. | 2 | $176 |
| Novartis Pharmaceuticals Corporation | 6 | $108 |
| PFIZER INC. | 4 | $72 |
| Amgen Inc. | 4 | $63 |
| E.R. Squibb & Sons, L.L.C. | 3 | $55 |
| Novo Nordisk Inc | 2 | $49 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| GENZYME CORPORATION | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Alnylam Pharmaceuticals Inc. | 1 | $18 |
Products named: QDOT MICRO, LEQVIO, ELIQUIS, REPATHA, Wegovy, VYNDAQEL, WAINUA, FABRAZYME.
Industry payments across MO — which companies pay providers there.
